Clinical Trials on Primary Peritoneal Cavity Cancer in Singapore
Total 100 results
-
National University of SingaporeUnknownHemodialysis | Peritoneal Dialysis | Stage 5 Chronic Kidney DiseaseSingapore
-
National Cancer Centre, SingaporeUnknownColorectal Cancer | Peritoneal MetastasesSingapore
-
Sutro Biopharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Korea, Republic of, Israel, Singapore, Canada
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Singapore
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), SingaporeCompletedCarcinoma of Urinary Bladder, SuperficialSingapore
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
National Healthcare Group, SingaporeCompletedDialysis; Complications | End Stage Renal Disease on Dialysis | Peritoneal Dialysis Catheter Exit Site InfectionSingapore
-
National University Hospital, SingaporeNational University of SingaporeActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Hormone Sensitive Prostate CancerSingapore
-
National University Hospital, SingaporeUnknownLocally Advanced Cervical CancerSingapore
-
National University Hospital, SingaporeUnknownBreast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid TumorsSingapore
-
Singapore General HospitalActive, not recruiting
-
National Cancer Centre, SingaporeUnknown
-
National Cancer Centre, SingaporeUnknownProstate CancerSingapore
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
National Cancer Centre, SingaporeFerring Pharmaceuticals; National Medical Research Council (NMRC), Singapore; Duke-NUS Graduate Medical School and other collaboratorsRecruitingNasopharyngeal Cancer | Prostate Cancer | Other CancerSingapore
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
National Cancer Centre, SingaporeRecruitingCervix Cancer | Image, BodySingapore
-
National University Hospital, SingaporeUnknownColorectal Cancer | Epithelial Ovarian Cancer | HNSCC | OrganoidsSingapore
-
National Cancer Centre, SingaporeCompleted
-
National University Hospital, SingaporeRecruiting
-
National University Hospital, SingaporeKK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...UnknownOvarian Cancer | Fallopian Tube CancerSingapore, Australia
-
National Cancer Centre, SingaporeTerminatedEpithelial Ovarian CancerSingapore
-
National University Hospital, SingaporeUnknownOvarian CancerSingapore
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
National Cancer Centre, SingaporeBristol-Myers Squibb; OncoQuest Pharma USA Inc.UnknownEpithelial Ovarian CancerSingapore
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
Sichuan Huiyang Life Science and Technology CorporationCompletedMelanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Colon CancerSingapore
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Gynecologic Oncology Trial & Investigation ConsortiumJapanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaJapan, United States, Hong Kong, Korea, Republic of, New Zealand, Singapore
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Canada, Israel, Switzerland, Australia, Singapore
-
BerGenBio ASATerminatedOvarian NeoplasmsKorea, Republic of, Singapore, United Kingdom, Norway
-
Zeria PharmaceuticalCompletedCervical CancerJapan, Korea, Republic of, Malaysia, Singapore, Taiwan, Thailand, Vietnam
-
ppharmaand GmbHBristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaboratorsActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete ResponseUnited States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated Carcinoma | Ovarian... and other conditionsUnited States, Canada, Singapore
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
Hoffmann-La RocheTerminatedAdvanced/Metastatic Head and Neck, Oesophageal and Cervical CancersKorea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
-
Astellas Pharma Singapore Pte. Ltd.CompletedProstate CancerHong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
Prelude TherapeuticsActive, not recruitingSarcoma | Breast Cancer | Glioblastoma | Malignant Mesothelioma | Endometrial Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung CancersUnited States, Singapore
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompletedCancer of the Uterine CervixUnited States, Singapore, Australia, New Zealand, India
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany